Literature DB >> 26351813

Lenvatinib/everolimus improves survival better than everolimus alone in metastatic renal cell cancer.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26351813

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  1 in total

Review 1.  Recent advances in the management of malignant pheochromocytoma and paraganglioma: focus on tyrosine kinase and hypoxia-inducible factor inhibitors.

Authors:  Rodrigo Toledo; Camilo Jimenez
Journal:  F1000Res       Date:  2018-07-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.